Soleno Therapeutics Inc (SLNO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	38.95% 91.73	66.02	32.66	-	-
Cost Of Revenue	24.36% 0.863	1.141	0.696	-	-
Gross Profit	40.06% 90.87	64.88	31.96	-	-
Operating Expenses	18.76% 52.15	43.91	39.18	45.74	59.12
Benefits Costs and Expenses	10.15% 48.37	43.91	39.18	41.96	-
Costs And Expenses	18.76% 52.15	43.91	39.18	45.74	-
Depreciation and Amortization	1.39% 0.509	0.502	0.502	0.504	0.503
Operating Income/Loss	79.04% 39.58	22.11	-6.525	-45.74	-59.12
Nonoperating Income/Loss	3.25% 3.781	3.908	1.817	1.97	3.134
Income/Loss From Continuing Operations Before Tax	96.15% 43.36	22.11	-4.708	-43.77	-55.98
Income/Loss From Continuing Operations After Tax	66.68% 43.36	26.01	-4.708	-43.77	-55.98
Net Income/Loss	66.68% 43.36	26.01	-4.708	-43.77	-55.98
Preferred Stock Dividends And Other Adjustments	0.415	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.51% 0.7947	53.33	50.48	46.18	1.2588
Diluted Average Shares	95.70% 2.362	54.92	50.48	46.18	1.2588
Basic Earnings Per Share	73.47% 0.85	0.49	-0.09	-0.95	-1.30
Diluted Earnings Per Share	78.72% 0.84	0.47	-0.09	-0.95	-1.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.87

0.18%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$139.44

0.28%

ONC

$288.30

0.99%